Who Paid My Doc
Infuse
Device Ophthalmology
General payments
$10,044,084
Research payments
$712,425
Through program year 2025, $10,044,084 in general payments and $712,425 in research payments were reported against Infuse (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,721,681 | 26,721 |
| 2024 | General | $2,440,667 | 30,408 |
| 2023 | General | $2,586,996 | 28,068 |
| 2023 | Research | $508,325 | 59 |
| 2022 | General | $1,495,284 | 20,172 |
| 2022 | Research | $204,100 | 22 |
| 2021 | General | $1,546,146 | 14,541 |
| 2020 | General | $253,310 | 403 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
120,313 general · 81 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.